Author

Laurie Wong

Institution: CytomX Therapeutics (United States)

Observed institutions: Genesys (United States), CytomX Therapeutics (United States)

ORCID: 0000-0002-6138-1551

Observed ORCID: 0000-0002-6138-1551

OpenAlex ID: A5047420193

A Probody T Cell–Engaging Bispecific Antibody Targeting EGFR and CD3 Inhibits Colon Cancer Growth with Limited Toxicity

2022 · Leila M. Boustany, Sherry L. LaPorte, et al. · Cancer Research · 70

A Functional Screen Identifies Lateral Transfer of -Glucuronidase (gus) from Bacteria to Fungi

2004 · P. Wenzl, Laurie Wong, et al. · Molecular Biology and Evolution · 61

Abstract A164: EGFR-CD3 bispecific Probody™ therapeutic induces tumor regressions and increases maximum tolerated dose >60-fold in preclinical studies

2018 · Leila M. Boustany, Laurie Wong, et al. · Molecular Cancer Therapeutics · 31

Abstract A203: CD3-EGFR bispecific Probody™ therapeutics induced tumor regressions and increased therapeutic window in preclinical studies

2015 · Sherry L. LaPorte, Daniel R. Hostetter, et al. · Molecular Cancer Therapeutics · 4

Abstract 3202: A probody drug conjugate targeting CD166 (ALCAM) enhances preclinical antitumor activity of a probody therapeutic targeting PD-1

2019 · Erwan Le Scolan, Tiffany Tse, et al. · Cancer Research · 3

Characterization of ELA026, a Clinical-Stage Monoclonal Antibody That Rapidly and Potently Depletes Myeloid Cells and T Lymphocytes

2022 · Eileen Rose, Stephen J. Moore, et al. · Blood · 2

Abstract 3202: A probody drug conjugate targeting CD166 (ALCAM) enhances preclinical antitumor activity of a probody therapeutic targeting PD-1

2019 · Erwan Le Scolan, Tiffany Tse, et al. · Immunology · 1

Data from A Probody T Cell–Engaging Bispecific Antibody Targeting EGFR and CD3 Inhibits Colon Cancer Growth with Limited Toxicity

2023 · Leila M. Boustany, Sherry L. LaPorte, et al.

Data from A Probody T Cell–Engaging Bispecific Antibody Targeting EGFR and CD3 Inhibits Colon Cancer Growth with Limited Toxicity

2023 · Leila M. Boustany, Sherry L. LaPorte, et al.

Supplementary Data from A Probody T Cell–Engaging Bispecific Antibody Targeting EGFR and CD3 Inhibits Colon Cancer Growth with Limited Toxicity

2023 · Leila M. Boustany, Sherry L. LaPorte, et al.

Metastatic Prostate Cancer Patients Treated With GVAX?? Vaccine for Prostate Cancer Develop Immunoreactivity to Filamin: Role of Filamin in Prostate Cancer Metastasis

2005 · Manjula Chinnappa, Laurie Wong, et al. · Journal of Immunotherapy

Works count: 11

Citation count: 172

H-index: 4

I10-index: 3